Normal Growth and Pubertal Development During Bromocriptine Therapy in Two Patients with Prolactinoma

5Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The cases of two boys, a 14 years 10 months old and an 18-year-old, with delayed puberty are presented. The first patient also had a short stature. Both patients had a pituitary adenoma, as shown by computed tomography, with high prolactin levels. After bromocriptine therapy was started, there was a spontaneous progression of normal puberty. The first patient used a synthetic growth hormone together with bromocriptine, however, even after the growth hormone was stopped progression in puberty and gain in height continued. The favorable response obtained in these patients implies that bromocriptine can be an effective therapy for adolescent patients with prolactinoma. © 1995, The Japan Endocrine Society. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Kamel, N., Uysal, A. R., Cesur, V., Erdoğan, G., & Ba͑kal, N. (1995). Normal Growth and Pubertal Development During Bromocriptine Therapy in Two Patients with Prolactinoma. Endocrine Journal, 42(4), 581–586. https://doi.org/10.1507/endocrj.42.581

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free